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–0.37, p  ! 0.001), German (n = –0.77, p  ! 0.001) and Hungar-
ian (r = –0.35, p  ! 0.05) women, and in PEs in Spanish (r = 
–0.67, p  ! 0.001) and German (r = –0.71, p  ! 0.001), but not in 
Hungarian (r = –0.02) women. Significant inverse correla-
tions were seen between  trans fatty acids and DHA in PEs at 
the 30th week of gestation (n = 241, r = –0.52, p  ! 0.001), at 
delivery (n = 241, r = –0.40, p  ! 0.001) and in cord lipids (n = 
218, r = –0.28, p  ! 0.001).  Conclusion: Because humans can-
not synthesize  trans  isomeric fatty acids, the data obtained 
in the present study support the concept that high maternal 
 trans isomeric fatty acid intake may interfere with the avail-
ability of LCPUFA both for the mother and the fetus. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Docosahexaenoic acid (C22: 6n–3, DHA) is an indis-
pensable component of cell membranes and is incorpo-
rated in high concentrations into membrane phospholip-
ids of brain and retina  [1, 2] . Randomized controlled tri-
als found that enhanced availability of DHA during fetal 
 [3, 4] or infantile  [5] life may be associated with better 
outcome at tests investigating long-term cognitive and vi-
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 Abstract 
 Background:  trans unsaturated fatty acids are thought to 
interfere with essential fatty acid metabolism. To extend our 
knowledge of this phenomenon, we investigated the rela-
tionship between  trans isomeric and long-chain polyunsatu-
rated fatty acids (LCPUFA) in mothers during pregnancy and 
in their infants at birth.  Methods: Fatty acid composition of 
erythrocyte phosphatidylcholine (PC) and phosphatidyleth-
anolamine (PE) was determined in Spanish (n = 120), German 
(n = 78) and Hungarian (n = 43) women at the 20th and 30th 
week of gestation, at delivery and in their newborns.  Re-
sults: At the 20th week of gestation, the sum of  trans fatty 
acids in PE was significantly (p  ! 0.01) lower in Hungarian 
[0.73 (0.51), % wt/wt, median (IQR)] than in Spanish [1.42 
(1.36)] and German [1.30 (1.21)] women. Docosahexaenoic 
acid (DHA) values in PE were significantly (p  ! 0.01) higher in 
Hungarian [5.65 (2.09)] than in Spanish [4.37 (2.60)] or Ger-
man [4.39 (3.3.2)] women. The sum of  trans  fatty acids sig-
nificantly inversely correlated to DHA in PCs in Spanish (r = 
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sual development. Accumulating evidence suggests that 
the human fetus may benefit from an enhanced maternal 
dietary intake of DHA [for a recent review of randomized 
controlled trials, see  6 ]; it has recently been recommend-
ed that pregnant and lactating women should aim to 
achieve an average daily intake of at least 200 mg DHA 
 [7] .
 However, intakes of essential fatty acids and their lon-
ger-chain metabolites may not be the only dietary factors 
influencing the availability of long-chain polyunsaturat-
ed fatty acids (LCPUFAs) to the fetus. Data from a grow-
ing number of observational studies indicate that unsatu-
rated fatty acids containing double bonds in  trans stereo-
isomeric configuration may exert untoward effects not 
only on cardiovascular health in adults [for a recent re-
view, see  8 ] but on essential fatty metabolism in the peri-
natal period as well. Significant inverse correlations were 
reported between  trans isomeric fatty acids and LCPU-
FAs in cord blood lipids both in healthy full-term infants 
 [9] and in full-term infants with an atopic trait  [10] , in 
cord vessel wall lipids in healthy full-term infants  [11] as 
well as in plasma lipids in young preterm infants  [12] . 
Similarly, an inverse association was found between  trans 
isomeric fatty acids and LCPUFA in human milk both at 
the 6th week  [13] and 6th month  [14] of lactation. These 
data raise concerns about the nutritional adequacy of 
high maternal  trans fatty acid intake in the perinatal pe-
riod.
 To extend our knowledge about the relationship be-
tween  trans isomeric fatty acids and LCPUFA, we studied 
the fatty acid composition of erythrocyte membrane 
samples collected in a multicenter, randomized, double-
blind, placebo-controlled European study where preg-
nant women were supplemented either with a fish oil, 
with 5-methyltetrahydrofolic acid, or both, or with pla-
cebo from the 22nd week of gestation until delivery.
 Subjects and Methods 
 Study Design 
 In this multicenter, randomized, double-blind, placebo-con-
trolled supplementation study we investigated the fatty acid com-
position of erythrocyte membrane phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE) in venous blood samples in size-
able groups of German, Hungarian and Spanish mothers at the 
20th and 30th week of gestation and at delivery as well as in ve-
nous cord blood of their newborns. A detailed description of the 
study design, recruitment of subjects, dietary intervention, data 
collection, collection of biological material and power calculation 
was published elsewhere  [15] .
 Briefly, apparently healthy pregnant women were recruited 
before the 20th week of gestation in the Departments of Obstet-
rics at the Ludwig Maximilians University, Munich, Germany, 
the University of Granada, Granada, Spain, and the University of 
Pécs, Pécs, Hungary. This study was conducted according to the 
guidelines laid down in the Declaration of Helsinki and all pro-
cedures involving human subjects were approved by the ethics 
committee of each participating center. After careful explanation 
of the study details, written informed consent was obtained from 
all subjects. 
 After inclusion in the study and before the 22nd week of gesta-
tion, participating women were randomly assigned to one of the 
four intervention groups. Each woman consumed daily one dose 
of the supplements providing either 500 mg DHA and 150 mg 
eicosapentaenoic acid (C20: 5n–3, EPA) (Pronova Biocare, Lysaker, 
Norway) or 400   g 5-methyltetrahydrofolic acid (BASF, Lud-
wigshafen, Germany), or both, or placebo together with vitamins 
and minerals in amounts meeting the recommended intakes dur-
ing the second half of pregnancy for European women. For the 
assessment of erythrocyte membrane PC and PE fatty acids 10 ml 
maternal venous blood was collected into EDTA at study entry 
and again at the 30th week of gestation. At delivery, 12 ml of ma-
ternal blood was collected into EDTA as well as 12 ml of venous 
placental cord blood.
 Laboratory Methods 
 For fatty acid analysis, the plasma was removed within 30 min 
and the erythrocyte mass was washed 3 times in isotonic sodium 
chloride solution. The last sediment was hemolyzed in 1 ml vol-
ume of distilled water for 20 min at ambient temperature, and 
then 2 ml ice-cold isopropylic alcohol with 0.5% butylated hy-
droxytoluolene (as antioxidant) was added drop-by-drop during 
continuous shaking. Thereafter, the samples were stored at –80  °  C 
until further analysis. All samples were thawed only once when 
lipids were extracted by adding 3 ml chloroform and the two in-
ternal standards (PE-heptadecanoate and PC-pentadecanoate es-
ters dissolved in methanol). The mixture was shaken on vortex 
and the lower layer was aspirated and evaporated under nitrogen 
stream. The dry lipid extract was resolved in chloroform and add-
ed to silica gel plates (Merck 60, 10  ! 20 cm). The mobile phase 
for the first run was hexane:diethylether:chloroform:acetic acid 
(21: 6:3: 1, vol/vol). The plate was dried under hood at ambient tem-
perature and ran again with chloroform:methanol:water (65: 25: 4, 
vol/vol). For positioning the PC and PE ester bands, the proper 
oleates were ran in parallel in every plate. The bands were stained 
with dichlorofluorescein, visualized under ultraviolet light and 
scrapped for transmethylation in 3  N HCl-methanol solution at 
84  °  C for 40 min.
 Fatty acids were analyzed by high-resolution capillary gas-liq-
uid chromatography (model 9001 gas chromatography; Finnigan/
Tremetrics, Austin, Tex., USA) with split injection, automatic 
sampler (A200SE, CTC Analytic, Switzerland) and flame ioniza-
tion detector with a DB-23 cyanopropyl column of 60 m length 
(J&W Scientific, Folsom, Calif., USA). Conditions during the 
analysis were as follows: temperature of injector at 80   °   C for 0.1 
min, temperature increase by 180   °   C per min up to 280   °   C, tem-
perature of column area at 60  °  C for 0.2 min, temperature increase 
by 40   °   C min up to 180   °   C, a 5-min hold period, temperature in-
crease by 1.5   °   C per min up to 200   °   C, an 8.5-min hold period, 
temperature increase by 40  °  C per min up to 240  °  C and a 13-min 
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hold period. The constant linear velocity was 0.3 m/s referred to 
100  °  C.
 For identification of sample peaks we used two commercially 
available fatty acid methyl ester calibration mixtures (Supelco 37 
FAME mix and NU-CHECK GLC reference 463) containing the 
fatty acids measured in the present study. These mixtures did not 
contain C22: 5n–6, and since its precursor, C22: 4n–6, coeluted 
with an unknown component, these two fatty acids were not in-
cluded in our study. Fatty acid results were expressed as percent-
ages (weight/weight) of fatty acids detected with a chain length 
between 14 and 24 carbon atoms. We detected three  trans iso-
mers in the PC fraction:  trans  hexadecenoic acid (C16: 1 t ),  trans 
octadecenoic acid (C18: 1 t ) and  trans octadecadienoic acid (C18: 
 2n–6 tt ); the sum of these three  trans isomers was entered into the 
correlation analysis as sum of the  trans  fatty acids. In the PE frac-
tion,  trans hexadecenoic acid coeluted with dimethyl acetal com-
pounds; hence, we were able to quantify only C18  trans fatty ac-
ids.
 Statistical Methods 
 We used SPSS for Windows, Release 15.0 (SPSS Inc., Chicago, 
Ill., USA) for the statistical analysis. The Kolmogorov-Smirnov 
test was used to evaluate the distribution of the data. Fatty acid 
compositional data among Spanish, German and Hungarian 
mothers were compared with the Kruskal-Wallis test. If this test 
indicated a significant variability of the data, the Bonferroni-cor-
rected Mann-Whitney test was used to identify differences be-
tween populations. 
 Spearman rho correlation coefficients were calculated to in-
vestigate separately the relationship between  trans isomeric fatty 
acids and LCPUFA at study entry, i.e. before intervention, for 
Spanish, German and Hungarian mothers. At later time points, 
i.e. during the intervention phase of the study, which means the 
30th week of gestation, delivery and cord blood, Pearson partial 
correlation analyses were carried out for the entire population af-
ter adjustment for the type of supplementation, nationality and 
normalization of data. Significance was set at p  ! 0.05 in all sta-
tistical analyses.
 Results 
 Comparison of Fatty Acid Profiles among Populations 
at Study Entry 
 Here we only describe the differences seen in the prin-
cipal fatty acids. Results of the statistical analyses for each 
and every fatty acid measured are shown in  table 1 for PC 
and in  table 2 for PE.
 Values of linoleic acid ( cis -9,  cis -12-C18: 2, LA) were 
significantly higher in Hungarian than in German and 
Spanish women in both PC and PE. Arachidonic acid 
(C20: 4n–6, AA) values were significantly lower in Ger-
man than in Hungarian and Spanish women in both PC 
and PE, and were significantly lower in Spanish than in 
Hungarian women in PE.   -Linolenic acid (C18: 3n–3, 
ALA) values were significantly lower in Spanish than in 
German and Hungarian women in both PC and PE. EPA 
values were significantly lower in Spanish than in Hun-
garian women in PC and PE. In PC, DHA values were 
significantly higher in Spanish than in German women. 
In PE, DHA values were significantly higher in Hungar-
ian than in German and Spanish women. 
 As to  trans isomeric fatty acids, C16: 1 t values were sig-
nificantly higher in German than in Hungarian women 
in PC. Values of C18: 1 t  in PE were significantly lower in 
Hungarian than in Spanish or German women and were 
significantly lower in German than in Spanish women, 
whereas no differences were seen in PC. In both PC and 
PE, C18: 2 tt values were significantly lower in Hungarian 
than in Spanish or German women.
 Association of  trans Isomeric Fatty Acids and 
LCPUFA in Maternal Lipids at Study Entry 
 C16: 1 t correlated significantly inversely with AA and 
DHA in PC in German mothers, whereas no correlation 
was seen in Spanish or Hungarian women. C18:  1 t corre-
lated significantly inversely with ALA in PE in Spanish 
and German mothers ( table  3 ). With the exception of 
DHA in PE in Hungarian women, statistically significant 
inverse correlations were seen between C18: 1 t  and both 
AA and DHA both in PC and PE in all the three popula-
tions. C18: 2n–6 tt correlated significantly inversely with 
LA in PC as well as with ALA in PE in Spanish women. 
Statistically significant inverse correlations were seen be-
tween C18: 2n–6 tt  and AA in PC in German and Hun-
garian and in PE in German and Spanish women. C18: 
 2n–6 tt correlated significantly inversely with DHA in 
both PC and PE in Spanish and German women. The 
sum of  trans isomeric fatty acids significantly inversely 
correlated with ALA in PE in Spanish and German wom-
en. Almost uniformly significant inverse correlations 
were seen between the sum of  trans  isomeric fatty acids 
and AA and DHA; the only exception was the lack of cor-
relation between the sum of  trans fatty acids and DHA in 
PE in Hungarian women. 
 Associations of  trans Isomeric Fatty Acids and 
LCPUFA in Maternal and Infantile Phospholipids 
during the Study 
 C16: 1 t correlated significantly positively with ALA in 
PC at the 30th week of gestation, whereas a significant 
inverse correlation was observed between C16: 1 t and AA 
at the 30th week of gestation ( table 4 ). C18: 1 t  correlated 
significantly inversely with LA in PE as well as with ALA 
in PE both at the 30th week of gestation and at delivery. 
Significant inverse correlations were seen between C18: 1 t 
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 and both AA and DHA in PE both at the 30th week of 
gestation and at delivery, whereas in PC significant in-
verse correlations were seen at the 30th week of gestation. 
No consistent results were seen when analyzing the as-
sociation of C18: 2n–6 tt  with LA and ALA. In contrast, 
C18: 2n–6 tt  correlated significantly and inversely with 
AA and DHA both at the 30th week of gestation and at 
delivery in PE and PC. Significant inverse correlations 
were seen between the sum of  trans  isomeric fatty acids 
and AA and DHA in maternal phospholipids; the only 
exception was the lack of correlation with DHA in PC at 
delivery. 
Table 1. F atty acid composition of erythrocyte membrane PC lipids at the 20th week of gestation in Spanish 
(n = 120), German (n = 78) and Hungarian (n = 43) pregnant women
Spanish German Hungarian
Saturated fatty acids
C14:0 0.39 (0.25)A, B 0.63 (0.33)A 0.59 (0.25)B
C16:0 33.19 (7.79)A, B 38.72 (9.20)A 37.99 (6.60)B
C18:0 19.18 (5.35)A, B 13.89 (6.58)A 13.15 (3.70)B
C20:0 0.31 (0.25)a, b 0.24 (0.24)a 0.23 (0.22)b
C22:0 0.26 (0.28) 0.24 (0.14) 0.23 (0.22)
C24:0 0.43 (0.50) 0.40 (0.31) 0.29 (0.31)
Sum of saturated 53.82 (4.60) 54.76 (4.12)a 52.95 (3.37)a
cis monounsaturated fatty acids
C16:1n–7 0.23 (0.18)A, B 0.43 (0.17)A 0.44 (0.19)B
C18:1n–9 14.57 (2.96)A, B 16.34 (1.90)A, C 13.06 (1.99)B, C
C18:1n–7 1.45 (0.36)A, a 1.72 (0.43)A 1.61 (0.37)a
C20:1n–9 0.33 (0.22)a 0.27 (0.11)a 0.27 (0.15)
C22:1n–9 0.09 (0.11)a 0.06 (0.07)A 0.12 (0.09)A, a
C24:1n–9 0.30 (0.65) 0.44 (0.50) 0.33 (0.56)
Sum of cis monounsaturated 17.38 (2.92)A, B 19.41 (2.60)A, C 16.40 (2.33)B, C
trans isomeric fatty acids
C16:1t 0.16 (0.16) 0.20 (0.16)a 0.14 (0.12)a
C18:1t 0.44 (0.39) 0.34 (0.67) 0.38 (0.36)
C18:2n–6tt 0.18 (0.15)a 0.16 (0.19)A 0.10 (0.12)A, a
Sum of trans 0.82 (0.53) 0.79 (0.90) 0.68 (0.43)
n–6 polyunsaturated fatty acids
C18:2n–6 14.24 (3.95)A 15.64 (3.26)B 17.50 (3.30)A, B
C18:3n–6 0.03 (0.09)A 0.04 (0.06)B 0.11 (0.15)A, B
C20:2n–6 0.55 (0.20)A, a 0.46 (0.13)A, B 0.62 (0.22)a, B
C20:3n–6 1.79 (0.69)A 1.63 (0.65)B 2.27 (0.64)A, B
C20:4n–6 7.68 (3.90)A 3.99 (3.62)A, B 6.59 (3.22)B
n–6 PUFA 24.31 (3.89)A, a 22.57 (5.20)a, B 28.01 (3.75)A, B
n–6 LCPUFA 9.88 (3.90)A 6.24 (3.87)A, B 9.84 (3.97)B
n–3 polyunsaturated fatty acids
C18:3n–3 0.08 (0.07)A, B 0.16 (0.10)A 0.14 (0.16)B
C20:3n–3 0.11 (0.16)A 0.06 (0.09)B 0.12 (0.14)A, B
C20:5n–3 0.09 (0.08)A 0.11 (0.10) 0.15 (0.15)A
C22:5n–3 0.61 (0.28)A 0.40 (0.68) 0.36 (0.40)A
C22:6n–3 2.29 (1.55)A 1.11 (1.79)A 1.84 (1.73)
n–3 PUFA 3.57 (1.81)A 1.84 (2.68)A 2.68 (2.41)
n–3 LCPUFA 3.43 (1.78)A, a 1.66 (2.63)A 2.52 (2.31)a
D ata are % weight/weight expressed as medians (range from the 1st to the 3rd quartile). Values in rows with 
the same superscript are significantly different. Mann-Whitney test was performed if Kruskal-Wallis analysis 
of variance showed significant variability of data. a, b p < 0.0167; A–C p < 0.001.
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 In cord blood, only one significant correlation was 
observed between  trans isomeric fatty acids and the par-
ent essential fatty acids LA and ALA. In contrast, all 
 trans  fatty acids showed a significant inverse correlation 
with both AA and DHA both in PC and PE in cord 
blood.
 Associations of Product-to-Substrate Ratios of 
Polyunsaturated Fatty Acid Synthesis and  trans 
Isomeric Fatty Acids in Maternal Lipids at Study 
Entry 
 Product-to-substrate ratios for the delta-6-desaturase 
enzyme in n–6 polyunsaturated fatty acid synthesis (di-
homo-  -linolenic acid/LA) as well as various other prod-
Table 2.  Fatty acid composition of erythrocyte membrane PE lipids at the 20th week of gestation in Spanish 
(n = 120), German (n = 78) and Hungarian (n = 43) pregnant women
Spanish German Hungarian
Saturated fatty acids
C14:0 0.26 (0.20)a, A 0.32 (0.18)a 0.38 (0.22)A
C16:0 24.24 (3.80)a 25.23 (5.16)a, A 22.57 (3.18)A
C18:0 12.58 (3.34)A 12.25 (3.23)B 10.05 (2.65)A, B
C20:0 0.37 (0.85)a 0.36 (0.45) 0.32 (0.23)a
C22:0 0.44 (0.92)A 0.46 (0.41)B 0.26 (0.26)A, B
C24:0 0.28 (0.43) 0.33 (0.39) 0.22 (0.21)
Sum of saturated 39.30 (7.29)A 40.24 (8.17)B 33.94 (5.31)A, B
cis monounsaturated fatty acids
C16:1n–7 1.03 (1.71)a, A 0.36 (0.20)A 0.43 (0.31)a
C18:1n–9 22.03 (4.14)a, A 23.80 (4.94)a, B 20.10 (2.79)A, B
C18:1n–7 1.17 (0.27)A 1.22 (0.26) 1.31 (0.38)A
C20:1n–9 0.57 (0.28) 0.56 (0.31) 0.60 (0.28)
C22:1n–9 0.14 (0.13) 0.12 (0.13) 0.16 (0.20)
C24:1n–9 0.41 (0.63) 0.28 (0.76) 0.33 (0.48)
Sum of cis monounsaturated 25.89 (3.87)A 26.73 (4.60)B 23.36 (3.43)A, B
trans fatty acids
C18:1t 1.19 (1.18)a, A 1.07 (1.13)a, b 0.68 (0.44)b, A
C18:2n–6tt 0.18 (0.17)a 0.19 (0.13)A 0.09 (0.13)a, A
Sum of trans 1.42 (1.36)A 1.30 (1.21)a 0.73 (0.51)A, a
n–6 polyunsaturated fatty acids
C18:2n–6 5.92 (1.21)a 5.72 (1.33)A 6.40 (1.65)a, A
C18:3n–6 0.02 (0.20)a, A 0.08 (0.10)a 0.11 (0.22)A
C20:2n–6 0.67 (0.39)A 0.57 (0.25)A, a 0.69 (0.30)a
C20:3n–6 1.18 (0.44)a 1.19 (0.47) 1.32 (0.57)a
C20:4n–6 17.31 (5.79)a, A 15.74 (7.23)a, B 23.10 (4.57)A, B
n–6 PUFA 25.56 (5.62)A, a 23.74 (6.88)B, a 31.99 (4.10)A, B
n–6 LCPUFA 19.55 (5.83)A, a 17.87 (6.93)B, a 25.75 (4.24)A, B
n–3 polyunsaturated fatty acids
C18:3n–3 0.12 (0.07)A, B 0.19 (0.14)A 0.22 (0.20)B
C20:3n–3 0.42 (0.32)A, a 0.26 (0.24)A 0.24 (0.35)a
C20:5n–3 0.26 (0.24)a 0.37 (0.37) 0.35 (0.30)b, a
C22:5n–3 1.59 (0.74)A, B 2.11 (1.50)A 2.18 (0.65)B
C22:6n–3 4.37 (2.60)A 4.39 (3.32)a 5.65 (2.09)A, a
n–3 PUFA 6.93 (3.01)A 7.41 (5.00) 9.03 (2.62)A
n–3 LCPUFA 6.79 (2.91)A 7.27 (4.84) 8.79 (2.80)A
D ata are % weight/weight expressed as medians (range from the 1st to the 3rd quartile). Values in rows with 
the same superscript are significantly different. The Bonferroni-corrected Mann-Whitney test was performed 
if Kruskal-Wallis analysis of variance showed significant variability of data. a, b p < 0.0167; A, B p < 0.001.
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uct-to-substrate ratios characterizing synthetic pathway 
activity are shown in  table 5 . All statistically significant 
associations indicated inverse relations between  trans 
isomeric fatty acids and the activity of LCPUFA synthe-
sis.
 Discussion 
 The present study is an analytical extension of a ran-
domized, controlled dietary supplementation trial car-
ried out in pregnant women living in three European 
countries presumably with a different amount of DHA in 
their natural diet. The assumption of different natural 
dietary DHA intakes in the three study populations was 
confirmed later on by the analysis of food frequency 
questionnaire data recorded during the study  [16] . Either 
expressed in absolute amounts or adjusted for energy in-
takes, the amount of DHA was significantly higher in the 
diet of Spanish than in the diet of German or Hungarian 
mothers. Absolute amounts of DHA intakes were also 
significantly higher in Hungarian than in German moth-
ers  [16] ; however, this difference disappeared following 
adjustment for energy intakes. 
Table 3.  Spearman correlation coefficients between polyunsaturated and trans isomeric fatty acids in erythrocyte membrane lipids in 
Spanish (n = 120), German (n = 78) and Hungarian (n = 43) expecting women investigated at the 20th week of gestation
Fatty acid PC PE
Spanish German Hungarian Spanish German Hungarian
Linoleic acid (C18:2n–6)
C16:1n–7t 0.03 0.13 –0.05 n.d. n.d. n.d.
C18:1n–7/9t –0.11 –0.16 0.06 0.05 –0.03 –0.06
18:2n–6tt –0.29b –0.06 0.19 –0.01 –0.10 –0.01
Sum of trans isomeric –0.17 –0.12 0.11 0.05 –0.03 –0.05
Arachidonic acid (C20:4n–6)
C16:1n–7t 0.05 –0.36b 0.11 n.d. n.d. n.d.
C18:1n–7/9t –0.29b –0.71c –0.45b –0.45c –0.50c –0.37a
C18:2n–6tt –0.15 –0.62c –0.39a –0.29b –0.48c –0.24
Sum of trans –0.28b –0.77c –0.47 –0.45c –0.51c –0.38a
a-Linolenic acid (C18:3n–3)
C16:1n–7t 0.03 0.19 0.21 n.d. n.d. n.d.
C18:1n–7/9t –0.02 0.06 0.06 –0.26b –0.24a –0.13
C18:2n–6tt 0.05 0.22 0.20 –0.28b –0.08 –0.01
Sum of trans 0.06 0.13 0.16 –0.26b –0.23a –0.15
EPA (C20:5n–3)
C16:1n–7t –0.33c –0.34a 0.27 n.d. n.d. n.d.
C18:1n–7/9t –0.19 –0.46c –0.44a –0.37c –0.27a –0.07
C18:2n–6tt –0.23a –0.38b –0.31a –0.47c –0.09 0.07
Sum of trans –0.13 –0.48c –0.39a –0.41c –0.25a –0.01
Docosapentaenoic acid (C22:5n–3)
C16:1n–7t 0.11 –0.34a 0.12 n.d. n.d. n.d.
C18:1n–7/9t –0.33c –0.72c –0.31a –0.41c –0.68c 0.06
C18:2n–6tt –0.02 –0.69c –0.40b –0.36c –0.54c –0.08
Sum of trans –0.24a –0.80c –0.36a –0.42c –0.69c 0.05
DHA (C22:6n–3)
C16:1n–7t 0.18 –0.31a 0.11 n.d. n.d. n.d.
C18:1n–7/9t –0.43c –0.73c –0.34a –0.68c –0.69c –0.03
C18:2n–6tt –0.22a –0.68c –0.23 –0.50c –0.51c –0.11
Sum of trans –0.37c –0.77c –0.35a –0.67c –0.71c –0.02
Su perscripts denote significant correlations: a p < 0.05; b p < 0.01; c p < 0.001. n.d. = C16:1t not detected.
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 The significantly higher contribution of DHA to PC 
seen in Spanish compared to German or Hungarian 
mothers at study entry can easily be explained on the ba-
sis of the differences seen in DHA intake. Indeed, statisti-
cally significant positive correlations were reported be-
tween dietary DHA intake and erythrocyte membrane 
DHA values both in small (n = 35) and sizeable (n = 1,550) 
cohorts of pregnant women  [17, 18] . However, the signif-
icantly higher contribution of DHA to PE in Hungarian 
compared to Spanish or German mothers can only part-
ly be explained by dietary DHA intakes, namely, that the 
diet of Hungarian mothers contained significantly high-
er absolute amounts of DHA than the diet of German 
mothers. In contrast, dietary DHA intakes cannot ex-
plain the difference seen between Spanish and Hungari-
an mothers in PE. Moreover, there were entirely contra-
dictory results when DHA values were compared be-
tween Spanish and Hungarian mothers either in PC or in 
PE, i.e. significantly lower DHA in PC, but significantly 
higher DHA in PE in Hungarian compared to Spanish 
mothers. 
 One potential explanation for the apparent controver-
sy in DHA concentrations in PC between Spanish and 
Hungarian women at study entry may be related to  trans 
 isomeric fatty acids showing a different picture in PC and 
PE: while the contribution of  trans isomeric fatty acids to 
the fatty acid composition of PC did not differ between 
Spanish and Hungarian mothers, in PE Spanish mothers 
exhibited a significantly higher contribution of C18 
 trans  isomers than Hungarian women (higher by 80% 
in C18: 1 t  and by nearly 50% in C18: 2n–6 tt).  We are un-
aware of data on differences in the incorporation of  trans 
 isomeric fatty acids into erythrocyte membrane PC or 
PE. However, recently Harvey et al.  [19] compared the 
incorporation of LA and C18: 2n–6 tt into phospholipids, 
triacylglycerols and cholesteryl esters in human aortic 
endothelial cells. More  trans -9, trans -12-C18: 2 were en-
riched in phospholipids than  cis -9, cis -12-C18: 2, whereas 
similar levels of  cis -9, cis -12-C18: 2 and  trans -9, trans -12-
C18: 2 enrichment were observed in triacylglycerols, and 
no enrichment was seen in cholesteryl esters  [19] . These 
data suggest that the enrichment of  trans isomeric fatty 
acids may be different between PC and PE as well, as we 
actually observed in the present study, and this raises the 
possibility that the different availability of  trans isomeric 
fatty acids in the membrane may lead to further conse-
quences for membrane metabolism.
 trans  isomeric fatty acids may interfere either with the 
availability of DHA for the synthesis of membrane struc-
tures or with the local incorporation of preformed DHA 
molecules. As far as the potential influence of  trans fatty 
acids on DHA synthesis is concerned, it has been demon-
strated that feeding pregnant sows with high doses of 
 trans isomeric fatty acids resulted in a significant decrease 
of DHA to aortic tissue phospholipids of piglets investi-
Table 4.  Partial correlation coefficients between trans fatty acids 
and the principal n–3 and n–6 polyunsaturated fatty acids during 
pregnancy and in cord blood samples
30th week
(n = 241)
Delivery
(n = 241)
Cord blood
(n = 218)
PC
C18:2n–6
C16:1t +0.02 –0.02 +0.02
C18:1t –0.27c –0.26c –0.05
C18:2n–6tt –0.28c –0.19a –0.08
Sum of trans –0.24c –0.24b –0.03
C20:4n–6
C16:1t –0.30c –0.13 –0.32c
C18:1t –0.29c –0.04 –0.32c
C18:2n–6tt –0.25c –0.16a –0.40c
Sum of trans –0.40c –0.16a –0.49c
C18:3n–3
C16:1t +0.18a +0.12 +0.10
C18:1t –0.10 –0.03 –0.03
C18:2n–6tt –0.18b –0.04 –0.09
Sum of trans –0.06 +0.01 –0.01
C22:6n–3
C16:1t –0.13 –0.04 –0.27c
C18:1t –0.29c –0.13 –0.29c
C18:2n–6tt –0.20b –0.12 –0.22b
Sum of trans –0.35c –0.19 –0.40c
PE
C18:2n–6
C18:1t –0.08 –0.10 0.17a
C18:2n–6tt +0.14a +0.05 –0.07
Sum of trans –0.05 –0.08 0.17
C20:4n–6
C18:1t –0.47c –0.24c –0.38c
C18:2n–6tt –0.42c –0.34c –0.24b
Sum of trans –0.52c –0.27c –0.43c
C18:3n–3
C18:1t –0.27c –0.25c –0.13
C18:2n–6tt –0.09 –0.25c +0.12
Sum of trans –0.26c –0.27c –0.08
C22:6n–3
C18:19t –0.50c –0.40c –0.22b
C18:2n–6tt –0.35c –0.20b –0.28c
Sum of trans –0.52c –0.40c –0.28c
C orrelations were corrected for nationality and supplementa-
tion and were normalized before evaluating Pearson’s partial cor-
relation. a p < 0.05; b p < 0.01; c p < 0.001. 
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gated at the age of 3 days  [20] . This finding was in concert 
with the effect of  trans isomeric fatty acids to inhibit delta-
6-desaturase both in vitro  [21] and in rat liver microsomes 
 [22] , and was interpreted as the effect of hydrogenated fats 
to inhibit LCPUFA synthesis  [20] . It should also be noted 
that in the present study  trans isomeric fatty acids were 
significantly inversely related to the parent n–3 LCPUFA, 
ALA. This inverse relationship is usually not seen in oth-
er studies relating  trans fatty acids to LCPUFA, and may 
possibly reflect the lower  trans fatty acid content of mar-
garines and spreads with higher ALA contents.
 Incorporation of DHA into membrane lipids is seen as 
a complex process consisting of partitioning of dissolved 
DHA monomers into the membrane, transfer of mono-
mers from aggregates absorbed onto the membrane and 
fusion of aggregates with the membrane  [23] . The rate-
limiting step of DHA incorporation appears to be the dis-
sociation or desorption of the molecule from the donor 
system. It has been demonstrated that the increase of mo-
lecular length of the fatty acids in the donor medium by 
two CH 2 groups increases the half-times for the transfer 
by a factor of about 10  [24] . Furthermore, it has been dem-
onstrated that various membrane properties are also 
modified by the presence of  trans as compared to  cis iso-
meric fatty acids  [25] . On the basis of these considerations 
it seems to be plausible to assume that the presence of 
 trans double bonds may also affect DHA incorporation 
into PC and PE. Such an effect may explain, at least part-
ly, the apparent controversy seen in comparing DHA be-
tween Spanish and Hungarian women in PC or PE.
Table 5.  Spearman correlation coefficients between product-to-substrate ratios of polyunsaturated fatty acid synthesis and trans iso-
meric fatty acids in erythrocyte membrane lipids in Spanish (n = 120), German (n = 78) and Hungarian (n = 43) expecting mothers 
investigated at the 20th week of gestation
Fatty acid PC PE
Spanish German Hungarian Spanis h German Hungarian
DHGLA/LA
C16:1n–7t –0.20 –0.19 0.10 n.d. n.d. n.d.
C18:1n–7/9t –0.004 –0.44c –0.20 –0.37c –0.49c 0.24
C18:2n–6tt 0.07 –0.31ª –0.16 –0.17 –0.39c 0.08
Sum of trans isomeric –0.001 –0.46c –0.21 –0.36c –0.50c 0.25
AA/DHGLA
C16:1n–7t 0.002 –0.42b 0.07 n.d. n.d. n.d.
C18:1n–7/9t –0.24a –0.53c –0.32b –0.13 –0.07 –0.30
C18:2n–6tt –0.08 –0.59c –0.39b –0.11 –0.04 –0.14
Sum of trans –0.21a –0.62c –0.36a –0.13 –0.07 –0.31c
EPA/ALA
C16:1n–7t 0.24a –0.34a 0.08 n.d. n.d. n.d.
C18:1n–7/9t –0.13 –0.53c –0.45b –0.02 –0.01 0.08
C18:2n–6tt –0.19 –0.55c –0.45b –0.05 0.06 0.09
Sum of trans –0.13 –0.58c –0.48b –0.04 0.01 0.15
DPA/EPA
C16:1n–7t –0.25a –0.01 –0.05 n.d. n.d. n.d.
C18:1n–7/9t –0.21 –0.35b 0.08 0.16 –0.23a 0.11
C18:2n–6tt –0.23a –0.41b –0.04 –0.30b –0.39c 0.03
Sum of trans –0.02 –0.37b 0.02 0.19 –0.25a 0.07
DHA/DPA
C16:1n–7t 0.13 0.07 –0.07 n.d. n.d. n.d.
C18:1n–7/9t –0.17 0.11 0.10 –0.42c –0.12 –0.20
C18:2n–6tt –0.36c 0.24 –0.32a –0.30b –0.03 –0.20
Sum of trans –0.21a 0.16 0.14 –0.40c –0.13 –0.19
Sup erscripts denote significant correlations: a p < 0.05; b p < 0.01; c p < 0.001. DHGLA = Dihomo--linolenic acid (C20:3n–6); 
DPA = docosapentaenoic acid (C22:5n–3); n.d. = not detected.
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 As demonstrated in  table 3 , all relationships between 
 trans fatty acid concentrations and the n–6 and n–3 fatty 
acid levels studied were negative, and most of them were 
statistically significant as well. It is to be noted that  trans 
isomeric fatty acids were significantly and inversely re-
lated to the intermediary metabolites of DHA synthesis, 
i.e. to EPA and docosapentaenoic acid (C22: 5n–3) as well. 
Significance was less prominent for the Hungarians, 
however, which may be due to a power problem. Although 
the Hungarian group size seems acceptable,  trans fatty 
acid levels – and ‘ trans exposure ranges’ in particular – 
appear generally lower in the Hungarians than in the oth-
er groups. As a result, a significant  trans LCPUFA rela-
tionship may require a higher number of cases in the 
Hungarian group than in the other groups.
 The significant inverse associations seen between 
 trans isomeric fatty acids and DHA at study entry sup-
port further the concept of modifying effect of  trans  fat-
ty acids on DHA status. It would be tempting to interpret 
the significant and inverse relations between some  trans 
 fatty acids and various product-to-substrate ratios in 
LCPUFA synthesis as indicators of disturbed conversion 
of essential fatty acids to their longer-chain metabolites. 
However, the biochemical meaning of product-to-sub-
strate ratios in essential fatty acid metabolism has not yet 
been firmly established for plasma lipid classes, and even 
less is known about the potential meaning of such ratios 
in erythrocyte membrane lipids. Therefore, caution is 
needed in interpreting the apparently impressive data 
shown in  table 5 .
 To the best of our knowledge, the present study is the 
first to provide a detailed description of an inverse asso-
ciation  between  trans isomeric fatty acids and LCPUFA 
in blood samples of pregnant women, although compa-
rable results have been briefly mentioned by others  [26, 
27] . Moreover, enhancement of the average dietary DHA 
intake of the population (i.e. the supplementation used in 
half of the women participating in the present study) did 
not make the inverse association between  trans fatty acids 
and DHA disappear by the 30th week of gestation or by 
delivery. It is to be noted that the contribution of  trans 
fatty acids to erythrocyte membrane lipids in the present 
study was well in the range usually reported for healthy 
adults: 1–2% for C18: 1 t and 0.25–0.4% for C18: 2n–6 tt 
 [28–30] . Hence, the effect of  trans fatty acids in interfer-
ing with the availability of LCPUFA seems to manifest 
itself also at moderate  trans fatty acid and enhanced DHA 
intakes.
 The inverse association of  trans isomeric fatty acids 
with AA and DHA in venous cord blood lipids seen in the 
present study is in concert with previous reports on in-
verse association between  trans isomeric fatty acids and 
LCPUFA in venous cord blood plasma lipids in Austrian 
newborns  [10] , in cord blood vessel wall lipids in Dutch 
neonates  [11] and in venous blood plasma lipids in 4-day-
old German preterm infants  [12] . Higher intrauterine ex-
posure to  trans  fatty acids was related to untoward func-
tional outcomes in more than one study.  trans Fatty acids 
in umbilical cord blood vessel wall lipid showed a nega-
tive association with the so-called neurologic optimality 
score investigated in a group of 317 toddlers at the age of 
18 months  [31] . Moreover,  trans  fatty acids in maternal 
plasma lipids inversely correlated with birth weight and 
gestational age in a study on 44 Polish women  [32] , and 
percent calories from  trans fatty acids were positively and 
independently associated with fetal loss in a recent survey 
on 104 American women participating in the Princeton 
School cardiovascular risk study  [33] . Though no asso-
ciation between birth dimensions and maternal phos-
pholipid C18: 1 t  values were reported in a very recent 
study on 782 Dutch mother-infant pairs  [34] , the question 
remains open whether  trans fatty acids may affect obstet-
ric pregnancy outcomes  [33, 35] .
 In summary, we report inverse associations between 
 trans isomeric fatty acids and DHA in a sizeable group of 
European women investigated at three phases of preg-
nancy. Though these observational data do not allow a 
direct conclusion to be drawn on functional consequenc-
es of dietary  trans  fatty acid exposure to pregnant wom-
en, the results reported certainly raise further concerns 
about the nutritional adequacy of high  trans  fatty acid 
intakes during pregnancy.  
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